Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 6% in First Half of 2022

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 319.4 million yuan in the first half of 2022, down 6% year-on-year.

Meanwhile, the company posted 5.7 billion yuan in revenue, down 4.5% year-on-year.

At the end of the reporting period, it had 18.8 billion yuan in total assets and 11.3 billion yuan in total liabilities, with a liability-to-asset ratio of 60.1%.